AKERO
associated with 6 other trademarks
Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune ...

Words that describe this trademark:

nonalcoholic steatohepatitis nash  pharmaceutical preparations  autoimmune disorders  treatment  preparations  fibrosis  steatohepatitis  inflammatory  nash  compounds 

Serial Number:

88088292

Mark:

AKERO

Status:

Registered

Status Date:

11-15-2022

Filing Date:

Registration Number:

6901415

Registration Date:

11-15-2022

Goods and Services:

Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune disorders, cirrhosis, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis, retinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treatment of fatty liver diseases and disorders and Steatohepatitis and other related diseases and disorders

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

08-06-2019

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

MARSHALL, GERSTEIN & BORUN LLP

Correspondent Name:

Recent Trademark filings by this company